Last reviewed · How we verify

maintenance of anaesthesia with propofol

Centre Hospitalier Universitaire Dijon · FDA-approved active Small molecule

maintenance of anaesthesia with propofol is a Sedative-hypnotic agent Small molecule drug developed by Centre Hospitalier Universitaire Dijon. It is currently FDA-approved for Maintenance of general anaesthesia during surgical procedures, Sedation in intensive care unit patients requiring mechanical ventilation.

Propofol is a sedative-hypnotic agent that enhances inhibitory GABAergic neurotransmission in the central nervous system to maintain general anaesthesia.

Propofol is a sedative-hypnotic agent that enhances inhibitory GABAergic neurotransmission in the central nervous system to maintain general anaesthesia. Used for Maintenance of general anaesthesia during surgical procedures, Sedation in intensive care unit patients requiring mechanical ventilation.

At a glance

Generic namemaintenance of anaesthesia with propofol
SponsorCentre Hospitalier Universitaire Dijon
Drug classSedative-hypnotic agent
TargetGABA-A receptor
ModalitySmall molecule
Therapeutic areaAnaesthesia
PhaseFDA-approved

Mechanism of action

Propofol acts as a positive allosteric modulator of GABA-A receptors, increasing the frequency and duration of chloride channel opening. This hyperpolarizes neuronal membranes, suppressing neuronal firing and producing sedation, hypnosis, and unconsciousness. It is commonly used for induction and maintenance of general anaesthesia in surgical and critical care settings.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about maintenance of anaesthesia with propofol

What is maintenance of anaesthesia with propofol?

maintenance of anaesthesia with propofol is a Sedative-hypnotic agent drug developed by Centre Hospitalier Universitaire Dijon, indicated for Maintenance of general anaesthesia during surgical procedures, Sedation in intensive care unit patients requiring mechanical ventilation.

How does maintenance of anaesthesia with propofol work?

Propofol is a sedative-hypnotic agent that enhances inhibitory GABAergic neurotransmission in the central nervous system to maintain general anaesthesia.

What is maintenance of anaesthesia with propofol used for?

maintenance of anaesthesia with propofol is indicated for Maintenance of general anaesthesia during surgical procedures, Sedation in intensive care unit patients requiring mechanical ventilation.

Who makes maintenance of anaesthesia with propofol?

maintenance of anaesthesia with propofol is developed and marketed by Centre Hospitalier Universitaire Dijon (see full Centre Hospitalier Universitaire Dijon pipeline at /company/centre-hospitalier-universitaire-dijon).

What drug class is maintenance of anaesthesia with propofol in?

maintenance of anaesthesia with propofol belongs to the Sedative-hypnotic agent class. See all Sedative-hypnotic agent drugs at /class/sedative-hypnotic-agent.

What development phase is maintenance of anaesthesia with propofol in?

maintenance of anaesthesia with propofol is FDA-approved (marketed).

What are the side effects of maintenance of anaesthesia with propofol?

Common side effects of maintenance of anaesthesia with propofol include Hypotension, Respiratory depression, Bradycardia, Injection site pain, Apnea, Propofol infusion syndrome (with prolonged use).

What does maintenance of anaesthesia with propofol target?

maintenance of anaesthesia with propofol targets GABA-A receptor and is a Sedative-hypnotic agent.

Related